banner add

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

from NYT > Health https://ift.tt/MFGJ3z1
via IFTTT

No comments

Brenna Henn Wanted to Improve Genetic Medicine. Then Her N.I.H. Grant Was Cut.

Brenna Henn had a long-term grant to study the genetic diversity of Africans and people of African descent. Then her N.I.H. funding was cut....

Theme images by PLAINVIEW. Powered by Blogger.